34P-59131-01696
1 vaccination
2 coded responses
12 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 189 / PA
- Registered
- 2021-05-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-01
Registered in v-safe
-
2021-05-01
Dose 1 — Janssen/Johnson & Johnson
-
2021-05-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-05-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-05-08
Health check-in — day 7, dose 1Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-06-12
-
2021-07-31
Survey response — 3 months, dose 1MedDRA: Fatigue, Headache, Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: fatigued headaches nauseousMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-30
-
2022-05-01
Survey response — 12 months, dose 1MedDRA: Malaise — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: sickMedDRA releases: 2024-11 · check-in free text available
-
2022-05-01
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-01 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-01 | Unsuccessful |
Free text
Release 9 — 3 months, dose 1
Symptoms: fatigued headaches nauseous
Release 11 — 12 months, dose 1
Symptoms: sick
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nausea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release